Adagene Inc. (ADAG)
NASDAQ: ADAG · Real-Time Price · USD
2.930
-0.270 (-8.44%)
At close: Oct 1, 2026, 4:00 PM EDT
2.960
+0.030 (1.02%)
After-hours: Oct 1, 2026, 7:30 PM EDT
Adagene Market Cap
Adagene has a market cap or net worth of $196.73 million as of October 1, 2026. Its market cap has increased by 109.75% in one year.
Market Cap
196.73M
Enterprise Value
74.91M
1-Year Change
109.75%
Ranking
Category
Stock Price
$2.93
ChartMarket Cap Chart
Since the IPO on February 9, 2021, Adagene's market cap has decreased from $804.22M to $196.73M, a decrease of -75.54%. That is a compound annual growth rate of -22.08%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2026 | 196.73M | 120.85% |
| Dec 31, 2025 | 89.08M | 1.11% |
| Dec 31, 2024 | 88.10M | 4.06% |
| Dec 29, 2023 | 84.66M | 47.15% |
| Dec 30, 2022 | 57.54M | -83.64% |
| Dec 31, 2021 | 351.59M | -56.28% |
| Feb 9, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Keros Therapeutics | 223.65M |
| Yarrow Bioscience | 223.30M |
| Compugen | 220.71M |
| Cartesian Therapeutics | 218.14M |
| Anavex Life Sciences | 217.84M |
| Protalix BioTherapeutics | 216.74M |
| Eledon Pharmaceuticals | 214.74M |
| Alector | 214.38M |